UAK Tri-Axis Balanced Series IV-PR

Solanum lycopersicum

Tomato

Tier IVUAK Tri-Axis Balanced Series

Target Trait

2.13×

fold-change

Umami+Astringency+Kokumi balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-02418

Genomic Edits

GC Content

44.9%

Construct Length

5,790 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

mGluR1 + Polyphenol-astringency axis + CaSR

IFI Score

213

Pathway Edits

mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
Polyphenol-astringency axis pathway primary gene cluster for astringency (IFI-A) tri-axis component
CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
Tri-axis metabolic flux partitioning hub for concurrent UAK pathway operation
Cross-pathway regulatory circuit for balanced UAK triple-axis expression
Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: mGluR1, Polyphenol-astringency axis, and CaSR pathways simultaneously engineeredBalanced tri-axis expression strategy (UAK) with cross-pathway flux managementPEG-mediated co-transfection of axis constructs for rapid phenotypic screening of multi-axis combinations

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Tier IV UAK triple-axis construct for advanced multi-modal sensory architecture combining umami, astringency, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$3999 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-M All Modalities